Does Sea Buckthorn Visual Performance Meta-Analysis work?

The current Migaku evidence database contains 1 reusable source document for Sea Buckthorn Visual Performance Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - Results Orexin-A reduced motion-induced behavioral abnormalities, nausea, and vomiting in rat and cat models. [Cai X (2025); evidence level 1] - These benefits are likely mediated by the modulation of hypothalamic nuclei activity, enhanced stomach motility, and improved vestibular function. [Cai X (2025); evidence level 1] - Conclusion Animal model studies indicates that orexin-A mitigates motion sickness (MS) symptoms in animal models, but overall certainty is low to moderate owing to risk of bias and indirectness. [Cai X (2025); evidence level 1] - Background Sensory input mismatches among the vestibular system, autonomic control, and visual perception cause motion sickness. [Cai X (2025); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.